Controlled attenuation parameter (CAP) for the quantification of hepatic steatosis: Relation to body composition in patients with nonalcoholic fatty liver disease

Background: Hepatic fat accumulation is the hallmark of non-alcoholic fatty liver disease (NAFLD) but rapid non-invasive methods measuring hepatic steatosis are not available in clinical practice. The controlled attenuation parameter (CAP™) quantifies the degree of ultrasound attenuation based on vibration controlled transient elastography (VCTE™, FibroScan®; Echosens, Paris). Overweight/obesity is an important risk factor for NAFLD, which is considered to represent the common hepatic phenotype of the metabolic syndrome. Aim: Our aim was to assess the relationship between body composition and hepatic steatosis,…